BioSpace News Archive

MimiVax LLC, a clinical-stage biotechnology company in Buffalo, N.Y., USA, developing immunotherapeutics for cancer and autoimmune diseases, announced a clinical collaboration to assess the combination of SurVaxM and pembrolizumab.

Research includes a potential new drug for colorectal cancer, as well as new studies on geriatric oncology and supportive care medicine

Transplant Genomics, Inc. and Viracor announce the first available results from combining TruGraf® and TRAC™, which will be presented at the virtual 2020 American Transplant Congress.

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, introduced a series of offerings designed to both advance vital research and support physicians in treating cancer patients, despite the challenges of the COVID-19 pandemic.

In lieu of a daily in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement